eli lilly retatrutide press release 2024 2025 Lilly's triple G agonist boasts 28.7% weight loss in Phase III trial Lilly, with new data, to

The right temporoparietal junction in attention and social interaction: A transcranial magnetic stimulation study

3 Effective Tips for Successful Weight Management: Minimize distractions like your phone during meals to help prevent overeating and stay tuned into hunger cues

Circulating sDPP-4 is increased in obesity and insulin resistance but is not related to systemic metabolic inflammation

10.1093/eurjpc/zwad050 [DOI] [PubMed] [Google Scholar] 29.Bogers RP, Bemelmans WJE, Hoogenveen RT, Boshuizen HC, Woodward M, Knekt P, et al

District Court for the Southern District of New York alleges that Ozempic caused permanent vision loss due to non-arteritic anterior ischemic optic neuropathy (NAION)